Karuna Therapeutics Inc (DELISTED) (KRTX:DL)
329.83
0.00 (0.00%)
USD |
NASDAQ |
Mar 18, 16:00
Karuna Therapeutics Cash from Operations (TTM): -385.82M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -385.82M |
| September 30, 2023 | -353.52M |
| June 30, 2023 | -303.47M |
| March 31, 2023 | -278.83M |
| December 31, 2022 | -228.01M |
| September 30, 2022 | -156.25M |
| June 30, 2022 | -140.11M |
| March 31, 2022 | -129.50M |
| December 31, 2021 | -100.88M |
| September 30, 2021 | -116.82M |
| June 30, 2021 | -95.80M |
| Date | Value |
|---|---|
| March 31, 2021 | -82.69M |
| December 31, 2020 | -69.86M |
| September 30, 2020 | -53.73M |
| June 30, 2020 | -39.37M |
| March 31, 2020 | -33.15M |
| December 31, 2019 | -30.92M |
| September 30, 2019 | -30.97M |
| June 30, 2019 | -24.68M |
| March 31, 2019 | -20.79M |
| December 31, 2018 | -15.38M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-385.82M
Minimum
Dec 2023
-24.68M
Maximum
Jun 2019
-139.70M
Average
-100.88M
Median
Dec 2021
Cash from Operations (TTM) Benchmarks
| Bristol-Myers Squibb Co | 13.72B |
| RayzeBio inc (DELISTED) | -- |
| Icosavax Inc (DELISTED) | -71.48M |
| Madrigal Pharmaceuticals Inc | -324.23M |
| Theseus Pharmaceuticals Inc (DELISTED) | -49.63M |